Liposomal Encapsulation of Hydrophilic Glucuronides via Saponification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for loading hydrophobic drugs into liposomes face challenges such as premature 'burst' release, leakage, and poor retention, especially for hydrophilic drugs like glucuronides, which are not effectively addressed by existing loading techniques.
Innovation Solution
The method involves converting hydrophobic drugs into their glucuronide methylester form, which is more membrane-permeable, and then using a pH gradient to saponify this form into a glucuronide within liposomes, enhancing retention and stability by leveraging the internal high pH to hydrolyze the methylester group and trap the glucuronide inside.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hydrophobic drugs are loaded into liposomes, then drug delivery to target tissues is enabled, but premature burst release and leakage occur reducing therapeutic efficacy
Solution Approach 1:
The patent applies preliminary action by converting hydrophobic drugs to their glucuronide methylester form before loading into liposomes. This pre-modification enables the drug to be trapped inside the liposome through pH-dependent ionization, preventing premature release. The glucuronide methylester form is loaded into the liposome interior where it undergoes saponification to form the ionized glucuronide, which is then trapped due to its charged state.
Solution Approach 2:
The patent utilizes parameter changes by exploiting the pH gradient between the liposome interior (high pH) and exterior (low pH). The pH difference drives the ionization state of the glucuronide conjugate, enabling it to be trapped inside the liposome. At high internal pH, the glucuronide methylester is converted to ionized glucuronide, which cannot cross the lipid membrane, thus preventing leakage.
2Quantity of substance
If hydrophilic drugs like glucuronides are loaded into liposomes, then drug solubility is improved, but active loading at high concentrations is difficult
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of hydrophilic glucuronides to their methylester form, which increases membrane permeability. This structural parameter change enables active loading into preformed liposomes. After loading, the methylester is converted back to the ionized glucuronide form inside the liposome through saponification, achieving high concentration loading of hydrophilic drugs.
Solution Approach 2:
The patent uses the glucuronide methylester as an intermediary form that bridges the gap between hydrophilic glucuronides and lipophilic drug loading requirements. The methylester form acts as a mediator that can cross the lipid membrane, enabling active loading, and is then converted to the desired hydrophilic form inside the liposome.
3Ease of operation
If glucuronide methylester is loaded into liposomes, then membrane permeability is improved enabling active loading, but the methylester group must be hydrolyzed to trap the drug inside
Solution Approach 1:
The patent applies self-service by designing the liposome interior to contain alkaline conditions (high pH) that automatically trigger saponification of the glucuronide methylester. The liposome's internal environment self-regulates the conversion process, eliminating the need for external intervention. The high pH interior spontaneously hydrolyzes the methylester group, trapping the ionized glucuronide inside.
Solution Approach 2:
The patent utilizes parameter changes by exploiting the pH difference between liposome interior (high pH) and exterior (low pH). This parameter difference drives the saponification reaction inside the liposome, converting the lipophilic methylester to the hydrophilic ionized form, thereby trapping the drug without requiring additional complex processes.
Data Source
AI summary
Described herein is a method for loading a hydrophilic compound into liposomes after addition of an alkylester group to form an esterified compound. After loading, the alkylester is hydrolyzed to reform the hydrophilic compound inside the liposomes. Also described is a method for loading drugs under a glucuronide methylester form into liposomes. The glucuronide methylester form of the drug is saponified to a glucuronide form of the drug inside the liposomes for better drug retention. The glucuronide residue conjugated to drugs can be removed inside cells to regenerate the parental drug upon cell uptake, liposomal degradation and enzyme hydrolysis. In case of cancer, this method can be used to safely deliver drugs to tumors.